Streetbeat News

Products Services

THTX

Theratechnologies anticipates a supply disruption of EGRIFTA SV, which is expected to impact revenues in Q4 2024. Despite this, the company remains confident in achieving strong Adjusted EBITDA for the current fiscal year, with more details to be shared in their Q3 results in October.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 9:05 pm

THTX

Theratechnologies announced a potential temporary supply disruption for EGRIFTA SV in early 2025 due to a voluntary shutdown of a contract manufacturer's facility after an FDA inspection. The company plans to manage inventory to meet demand but expects a $1.6 million revenue shortfall for fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 9:03 pm

EDIT

Editas Medicine (NASDAQ:EDIT) has been evaluated by 4 analysts over the past three months, with a mix of bullish and indifferent ratings. The average 12-month price target is $11.75, down from a previous $14.00. Recent analyst actions include a buy rating from Jones Trading, a lowered equal-weight from Barclays, a lowered buy from Truist Securities, and a raised buy from B of A Securities. Editas Medicine is a clinical-stage genome editing company using CRISPR/Cas9 technology. Despite a significant revenue decline, the company maintains a strong net margin and low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 17, 2024 | 9:00 pm

BTCUSD

DOGEUSD

ETHUSD

Cryptocurrency markets, including Bitcoin, Ethereum, and Dogecoin, are trading higher ahead of the FOMC meeting, with Bitcoin seeing significant transaction volume increases. Analysts predict potential market movements based on the Fed's interest rate decision.

Portfolio Pulse from Khyathi Dalal

September 17, 2024 | 8:54 pm

META

SNAP

Snap Inc. unveiled its latest AR Spectacles at the annual Partner Summit, targeting developers to enhance AR capabilities. The glasses aim to transition AR from screens to a hands-free experience. Snap positions itself as a leader in AR, competing with Meta Platforms, which is also developing AR glasses.

Portfolio Pulse from Adam Eckert

September 17, 2024 | 8:51 pm

DIA

ENPH

HPE

IWM

MRNA

QQQ

SPY

The S&P 500, tracked by SPDR S&P 500 ETF Trust (SPY), hit record highs ahead of the Fed's interest rate decision, marking a 7-day winning streak. The Invesco QQQ Trust (QQQ) and SPDR Dow Jones Industrial Average ETF (DIA) closed flat, while iShares Russell 2000 ETF (IWM) rose 0.8%. Market expectations for the Fed's rate cut are mixed, with a 65% chance of a 50-basis-point cut. Enphase Energy, Hewlett Packard Enterprise, and Moderna were among the top gainers.

Portfolio Pulse from Piero Cingari

September 17, 2024 | 8:37 pm

CRM

NVDA

Salesforce and NVIDIA are collaborating to enhance AI capabilities for enterprises. They aim to integrate NVIDIA's AI platform with Salesforce's platform to optimize predictive and generative AI workflows.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 8:31 pm

AEHL

DHI

LEN

PHM

SPY

TGLS

TILE

Homebuilder and building product stocks are expected to benefit from potential Federal Reserve rate cuts, with historical trends showing outperformance in anticipation of such cuts. Stocks like Pulte Group, D.R. Horton, Lennar, and others have already seen gains, while the S&P 500 has had a modest increase.

Portfolio Pulse from Michael Juliano

September 17, 2024 | 8:22 pm

BLK

MSFT

BlackRock and Microsoft are collaborating to create a $30 billion fund aimed at investing in AI infrastructure. This partnership highlights the growing importance of AI technology and infrastructure in the financial and tech sectors.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 8:08 pm

EA

Electronic Arts (EA) anticipates its American football business to generate $1 billion in net bookings for the fiscal year 2025, indicating strong performance expectations for this segment.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 8:03 pm